Skip to content

Suprascapular and Axillary Versus Interscalene Blocks Regarding Phrenic Affection in Shoulder Surgeries

Comparative Study Between Combined Suprascapular and Axillary Nerve Blocks Versus Interscalene Nerve Block Regarding Phrenic Nerve Affection Assessed by Ultrasound Guided Diaphragmatic Excursion in Shoulder Arthroscopy Surgeries

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06674551
Enrollment
60
Registered
2024-11-05
Start date
2024-11-20
Completion date
2025-11-01
Last updated
2024-11-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Interscalene Nerve Block, Suprascapular Nerve, Shoulder Surgery

Keywords

interscalene nerve block, axillary nerve block, shoulder surgery

Brief summary

This study is aims to compare between combined suprascapular and axillary nerve blocks versus interscalene nerve block regarding phrenic nerve affection assessed by ultrasound guided diaphragmatic excursion in shoulder arthroscopy surgeries.

Detailed description

Interscalene approach of brachial plexus nerve block is recognized as the gold standard technique for postoperative pain control after shoulder arthroscopy surgeries . However, it is associated with major adverse effects and possibly critical complications including phrenic nerve affection. Combined suprascapular and axillary nerve blocks are considered to be a safe and effective alternative to interscalene nerve block for shoulder surgery. Futher studies had been done regarding postoperative analgesia after shoulder arthroscopy surgeries using intersalene nerve block versus suprascapular and axillary nerve blocks. In this study, we will Compare between combined suprascapular and axillary nerve blocks vs interscalene nerve block regarding objective phrenic nerve affection known as a serious complication of interscalene nerve block.

Interventions

PROCEDURESuprascapular nerve block and Axillary nerve block

A linear ultrasound probe will be placed in a sagittal plane at the superior medial border of the scapula. The probe will be moved laterally and then placed parallel to the scapular spine. when the needle tip contacts the bone just medial to the spinoglenoid notch and after confirmation of absence of vascular structure by color Doppler, 10 ml of 0.5% bupivacaine will be injected with aspiration every 3 ml to avoid intravascular injection and the spread of the local anaesthetic

The ultrasound probe will be placed in the supraclavicular fossa in a transverse orientation, aimed caudad into the thoracic cavity, to visualize the brachial plexus near the subclavian artery. Once identified, the plexus will be followed cephalad where it is found within the brachial plexus fascial sheath in the interscalene groove.

Sponsors

Ain Shams University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Patients aged between 18 - 60 years old. * Both sexes. * ASA physical status classes I - II. * Body mass index: 18-35 kg/ m2.

Exclusion criteria

* Infection at site of injection. * Psychiatric illness. * Central Nervous System Diseases like (epilepsy, stroke …etc.) or neurological disease affecting patient's upper limb. * Dependence on opiates and psycho-dynamic medications. * Moderate to severe pulmonary disease. * Coagulopathy and bleeding disorders. * Allergies to drug used (Bupivacaine 0.5%). * Previous surgery at site of injection and history of radiotherapy.

Design outcomes

Primary

MeasureTime frameDescription
incidence of hemidiaphragmatic paralysis measured by ultrasound.measurement will be taken 8 hours after the performance of the block for fourth and last time.defined as a ≥ 25% reduction in diaphragmatic excursion measured by ultrasound.

Secondary

MeasureTime frameDescription
postoperative pain using NRS24 hours postoperativeis to measure first rescue analgesia postoperative (24 hours)

Contacts

Primary ContactMohamed Khaled Mahmoud, Master
midoabbas2019@gmail.com+201211880428

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026